Morocco to Acquire Russian Sputnik V Vaccine, Expanding COVID-19 Immunization Options
Morocco is preparing to acquire the Russian Sputnik V vaccine against Covid-19. An agreement has recently been signed between the Russian Direct Investment Fund and the Moroccan pharmaceutical company "Galenica".
In a statement to TASS, Artyom Tsinamdzgvrishvili, head of the Moscow trade mission, noted that the first batches of doses to be sent to Morocco could be enough to "vaccinate more than 20% of the Moroccan population". According to the business manager, "Galenica", the distribution networks of the Russian vaccine can ensure distribution not only in Morocco, but also "in other African countries".
Thanks to the free trade agreements signed by Morocco with the EU, the United States, Turkey and several Arab and African countries, the Moroccan manufacturing company could become "a hub for the distribution of the vaccine in other countries in the region," he specified. As the first country to develop the Covid vaccine, Russia has conducted clinical trials with Sputnik V which would be effective, according to the laboratory, at 92%.
Related Articles
-
220 dirhams on construction sites, up to 400 in the fields: Morocco lacks workers
25 August 2026
-
This Israeli company equips defense giants and also has clients in Morocco
24 August 2026
-
After three days in Algeria, a sanctioned Russian ship passes near Morocco
24 August 2026
-
In Brussels, a Moroccan name and being over 50: the profile most disadvantaged in hiring
24 August 2026
-
Morocco Has a New Billionaire Forbes Has Yet to Spot
24 August 2026